Live Breaking News & Updates on Genmab Publishes

Genmab Publishes 2022 Annual ReportCompany AnnouncementCOPENHAGEN, Denmark; February 22, 2023 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2022. Below is a summary of business progress in 2022, financial performance for the year and the financial outlook for 2023. The fu. ....

New Jersey , United States , Marisol Peron , Andrew Carlsen , Janssen Biotech Inc , Global Communications Corporate Affairs , Drug Administration , Seagen Inc , Halozyme Therapeutics Inc , Exchange Commission , Abbvie Inc , European Medicines Agency , Company Announcement , Genmab Publishes , Annual Report , Biologics License Application , Priority Review , Prescription Drug User Fee Act , Marketing Authorization Application , European Medicines , Currency Hedge , Halozyme Therapeutics , Senior Vice President , Global Communications , Vice President , Y Shaped Genmab ,